Gaudium IVF And Women Health Shares Debut at ₹83 on BSE, Premium to Issue Price
Gaudium IVF And Women Health shares listed at ₹83 on BSE, higher than the ₹79 IPO issue price. The ₹4 premium reflects positive market sentiment toward the women's healthcare and fertility treatment company. The successful debut marks the company's entry into public equity markets.
*this image is generated using AI for illustrative purposes only.
Gaudium IVF And Women Health commenced trading on the Bombay Stock Exchange (BSE) with its shares listing at ₹83 per share, marking the company's entry into the public equity markets. The listing price represents a premium to the initial public offering (IPO) issue price.
Market Debut Performance
The healthcare company's shares opened at a price higher than the IPO issue price, demonstrating positive market reception. The listing details show:
| Parameter: | Details |
|---|---|
| Listing Price: | ₹83 |
| IPO Issue Price: | ₹79 |
| Premium: | ₹4 |
| Exchange: | BSE |
Company Background
Gaudium IVF And Women Health operates in the specialized healthcare sector, focusing on fertility treatments and women's health services. The company's public listing marks a significant milestone in its growth trajectory and provides access to capital markets for future expansion plans.
The positive listing performance reflects investor interest in the healthcare sector, particularly in specialized medical services. The premium listing provides early investors with immediate gains and establishes the company's market valuation above the IPO pricing.
19
